Crystal structure of N-(7-di-bromo-methyl-5-methyl-1,8-naphthyridin-2-yl)benzamide–pyrrolidine-2,5-dione (1/1)

Wang B.Z.; Zhou J.P.; Zhou Y.; Luo J.S.; Yang J.J.; Chi S.M.

首页> 外文期刊>Acta Crystallographica Section E: Crystallographic Communications >Crystal structure of N-(7-di-bromo-methyl-5-methyl-1,8-naphthyridin-2-yl)benzamide–pyrrolidine-2,5-dione (1/1)

【24h】

Crystal structure of N-(7-di-bromo-methyl-5-methyl-1,8-naphthyridin-2-yl)benzamide–pyrrolidine-2,5-dione (1/1)

机译：N-（7-二溴甲基-5-甲基-1,8-萘啶-2-基）苯甲酰胺-吡咯烷-2,5-二酮（1/1）的晶体结构

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The title compound, C17H13Br2N3O·C4H5NO2, is a co-crystal of N-(7-di-bromo-methyl-5-methyl-1,8-naphthyridin-2-yl)benzamide and pyrrolidine-2,5-dione (succinimide). The benzamide mol-ecule exhibits pseudo-mirror symmetry, with an r.m.s. deviation of the non-H atoms of 0.09?? (except for the two Br atoms). The angle between the least-squares planes of the two mol-ecules is 26.2?(2)°. In the crystal, the two mol-ecules are mutually linked by N—H?O and N—H?N hydrogen bonds. The packing is consolidated by C—H?(O,N) hydrogen bonds and π–π stacking inter-actions.

机译：标题化合物C17H13Br2N3O·C4H5NO2是N-（7-二溴甲基-5-甲基-1,8-萘啶-2-基）苯甲酰胺和吡咯烷-2,5-二酮（琥珀酰亚胺）的共晶体）。苯甲酰胺分子具有假镜对称性，其r.m.s。非H原子的偏差为0.09≤ε。（两个Br原子除外）。两个分子的最小二乘平面之间的夹角为26.2°（2）°。在晶体中，两个分子珠通过NH 3 O和NH 3 N氢键相互连接。填料通过CH-H（O，N）氢键和π-π堆积相互作用进行固结。

著录项

来源
《Acta Crystallographica Section E: Crystallographic Communications》 |2017年第1期|共3页
作者
Wang B.Z.; Zhou J.P.; Zhou Y.; Luo J.S.; Yang J.J.; Chi S.M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类晶体学;
关键词

相似文献

外文文献
中文文献
专利

1. N-(7-Dibromomethyl-5-methyl-1,8-naphthyridin-2-yl)acetamide–pyrrolidine-2,5-dione (1/1) [J] . Chi S.-M., Gou G.-Z., Kou J.-F., Acta Crystallographica Section E: Crystallographic Communications . 2013,第2期

机译：N-（7-二溴甲基-5-甲基-1,8-萘啶-2-基）乙酰胺–吡咯烷-2,5-二酮（1/1）
2. N-(7-Dibromomethyl-5-methyl-1,8-naphthyridin-2-yl)acetamide–pyrrolidine-2,5-dione (1/1) [J] . Chi S.-M., Gou G.-Z., Kou J.-F., Acta Crystallographica Section E: Crystallographic Communications . 2013,第2期

机译：N-（7-二溴甲基-5-甲基-1,8-萘啶-2-基）乙酰胺–吡咯烷-2,5-二酮（1/1）
3. Crystal structures of the dioxane hemisolvates of N-(7-bromomethyl-1,8-naphthyridin-2-yl)acetamide and bis[N-(7-dibromomethyl-1,8-naphthyridin-2-yl)acetamide] [J] . Rosin R., Seichter W., Mazik M. Acta Crystallographica Section E: Crystallographic Communications . 2017,第10期

机译：N-（7-溴甲基-1,8-萘啶-2-基）乙酰胺和双[N-（7-二溴甲基-1,8-萘啶-2-基）乙酰胺]的二恶烷半溶剂化物的晶体结构
4. Synthesis of N-(2,3-dihydro-1-~14Cmethyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-benzamide and N-(2,3-dihydro-l-~14Cmethyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl) - N -~14C methyl-benzamide as novel carbon-14 labelled CCK Antagonists [C] . Gholamhossein Shirvani, Hojatollah Matloubi Nader Saemian International Conference on Isotopes (5ICI) . 2005

机译：N-（2,3-二氢-1- 〜14℃甲基-2-氧代-5-苯基-1H-1,4-苯并二氮哌己嘧啶-3-基-3-基（2,3-二氢）的合成-1- 〜14c甲基-2-氧代-5-苯基-1H-1,4-苯并二氮嘧啶-3-基） - N - 〜14C甲基 - 苯甲酰胺作为新型碳-14标记的CCK拮抗剂
5. X-ray Crystal Structures Of: [Rh2(N-{2,4,6-CH 3}C6H2)COCH3)4]˙2NCC 6H4 and Ba1.5[Fe(C10H13N 2O7)][Co(CN)6]˙9H2O; Two Crystallographic Challenges [D] . Kpogo, Kenneth Kwame. 2013

机译：X射线晶体结构：[RH2（N- {2,4,6-CH 3} C6H2）COCH3）4]χ2NCC6H4和BA1.5 [Fe（C10H13N 2O7）] [CO（CN）6]˙ 9H2O;两个晶体挑战
6. Crystal structure and Hirshfeld surface analysis of N-(2-chlorophenylcarbamothioyl)-4-fluorobenzamide and N-(4-bromophenylcarbamothioyl)-4-fluorobenzamide [O] . Sidra Akhter, Muhammad Iqbal Choudhary, Hina Siddiqui, 2019

机译：N-（2-氯苯基苯基氨基甲酰基硫基基）-4-氟苯甲酰胺和N-（4-溴苯基苯基氨基甲酸硫基基）-4-氟苯甲酰胺的晶体结构和Hirshfeld表面分析
7. Crystal structure of N-(7-dibromomethyl-5-methyl-1,8-naphthyridin-2-yl)benzamide–pyrrolidine-2,5-dione (1/1) [O] . Bang Zhong Wang, Jun Ping Zhou, Yong Zhou, 2017

机译：N-（7-二溴甲基-5-甲基-1,8-萘啶-2-基）苯甲酰胺 - 吡咯烷-2,5-二酮（1/1）的晶体结构

Crystal structure of N-(7-di-bromo-methyl-5-methyl-1,8-naphthyridin-2-yl)benzamide–pyrrolidine-2,5-dione (1/1)

摘要

著录项

相似文献

相关主题

期刊订阅